Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData Read more
Second wave of COVID-19 vaccines may not be needed to reach higher efficacy bar than first batch Read more
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more